Dr., Professor and Ph.D. Supervisor at the School of Pharmacy, Zhejiang University. Concurrently serves as Standing Committee Member of the Pharmacogenomics Professional Committee of the Chinese Pharmacological Society and Honorary Director of the Biochemical Drugs Professional Committee of the Zhejiang Pharmaceutical Association. Published 240 papers in journals such as Cell, Nature Communications, Advanced Materials, and Biomaterials, as well as edited 16 books and textbooks. Led five National Natural Science Foundation projects (including two key projects), two sub-projects under the National Major New Drug Innovation Initiative, and one key project under the National Key R&D Program's "Precision Medicine Research" initiative. Completed five scientific research achievements, receiving the Zhejiang Provincial Science and Technology Progress Third Prize twice, the Zhejiang Provincial Science and Technology Progress Second Prize once, the Zhejiang Provincial Natural Science Second Prize once, and the Zhejiang Provincial Natural Science Third Prize once. Recognized as a Zhejiang Provincial Leading Talent in Scientific and Technological Innovation. Developed an individualized tumor vaccine from scratch, which has received clinical trial approval from China's CDE and the U.S. FDA, and is currently advancing through clinical trials.